BSE Live
Oct 29, 16:01Prev. Close
783.35
Open Price
793.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 29, 15:54Prev. Close
784.00
Open Price
782.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
773.75 (285)
| Balance Sheet of Senores Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 46.05 | 30.51 | 9.82 | 8.74 | 3.80 | |
| Total Share Capital | 46.05 | 30.51 | 9.82 | 8.74 | 3.80 | |
| Reserves and Surplus | 661.91 | 137.61 | 29.11 | 25.01 | 5.67 | |
| Total Reserves and Surplus | 661.91 | 137.61 | 29.11 | 25.01 | 5.67 | |
| Total Shareholders Funds | 707.96 | 168.12 | 38.93 | 33.75 | 9.47 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 76.26 | 19.88 | 24.17 | 2.09 | 3.20 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 7.12 | 6.57 | 1.58 | 0.00 | 0.00 | |
| Long Term Provisions | 1.51 | 0.65 | 0.26 | 0.05 | 0.00 | |
| Total Non-Current Liabilities | 84.89 | 27.10 | 26.01 | 2.15 | 3.20 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 17.71 | 72.88 | 36.24 | 12.39 | 0.50 | |
| Trade Payables | 13.10 | 11.63 | 4.39 | 6.05 | 0.13 | |
| Other Current Liabilities | 9.63 | 5.89 | 6.07 | 0.21 | 1.45 | |
| Short Term Provisions | 0.80 | 0.25 | 0.08 | 0.14 | 0.20 | |
| Total Current Liabilities | 41.24 | 90.65 | 46.78 | 18.78 | 2.29 | |
| Total Capital And Liabilities | 834.09 | 285.86 | 111.72 | 54.68 | 14.96 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 54.57 | 24.09 | 7.21 | 0.02 | 0.00 | |
| Intangible Assets | 0.02 | 0.00 | 0.56 | 1.13 | 1.69 | |
| Capital Work-In-Progress | 34.01 | 14.88 | 8.06 | 0.00 | 0.00 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 88.60 | 42.56 | 19.10 | 4.31 | 4.41 | |
| Non-Current Investments | 104.38 | 81.58 | 8.23 | 11.69 | 1.45 | |
| Deferred Tax Assets [Net] | 0.30 | 0.21 | 0.18 | 0.34 | 0.77 | |
| Long Term Loans And Advances | 224.33 | 98.63 | 55.07 | 23.11 | 0.00 | |
| Other Non-Current Assets | 4.41 | 22.94 | 1.46 | 0.00 | 0.14 | |
| Total Non-Current Assets | 422.02 | 245.90 | 84.04 | 39.45 | 6.76 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 8.66 | 4.52 | 3.12 | 0.58 | 0.34 | |
| Trade Receivables | 25.69 | 22.01 | 15.73 | 10.78 | 0.23 | |
| Cash And Cash Equivalents | 359.72 | 10.44 | 0.09 | 1.54 | 1.64 | |
| Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 2.32 | 5.99 | |
| OtherCurrentAssets | 18.00 | 2.99 | 8.74 | 0.00 | 0.00 | |
| Total Current Assets | 412.07 | 39.96 | 27.68 | 15.23 | 8.20 | |
| Total Assets | 834.09 | 285.86 | 111.72 | 54.68 | 14.96 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 171.97 | 23.28 | 0.00 | 0.13 | 0.13 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.65 | 0.88 | 0.00 | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | 235.04 | 144.92 | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 104.38 | 81.58 | 8.23 | 0.02 | 0.00 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |